Senescence and senotherapeutics: a new field in cancer therapy-Reference-Cited by-同舟云学术

Senescence and senotherapeutics: a new field in cancer therapy

Published:2019-01 Issue: Volume:193 Page:31-49
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Myrianthopoulos Vassilios,Evangelou Konstantinos,Vasileiou Panagiotis V.S.,Cooks Tomer,Vassilakopoulos Theodoros P.,Pangalis Gerassimos A.,Kouloukoussa Myrsini,Kittas Christos,Georgakilas Alexandros G.,Gorgoulis Vassilis G.

Funder

European Union

Welfare Foundation for Social & Cultural Sciences

NKUA-SARG

EPTRI

DAAD

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference237 articles.

1. Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition;Abla;Hematology. American Society of Hematology. Education Program,2015

2. Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management;Adhami;Biochemical Pharmacology,2012

3. Characterization of novel markers of senescence and their prognostic potential in cancer;Althubiti;Cell Death & Disease,2014

4. Rapamycin: an InhibiTOR of aging emerges from the soil of easter island;Arriola Apelo;The Journals of Gerontology: Series A,2016

5. Chapter 32 - Quercetin A2;Ay,2016

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy-induced senescence in breast cancer: an overview;Exploration of Targeted Anti-tumor Therapy;2024-07-25

2. Cellular Senescence in Germ Cell Neoplasia In Situ (GCNIS) and Other Histological Types of Testicular Cancer;Medicina;2024-07-08

3. Selective induction of senescence in cancer cells through near‐infrared light treatment via mitochondrial modulation;Journal of Biophotonics;2024-06-21

4. Disruptors of sestrin-MAPK interactions rejuvenate T cells and expand TCR specificity;2024-05-21

5. Non-oncogene dependencies: Novel opportunities for cancer therapy;Biochemical Pharmacology;2024-05